We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
3 Top-Ranked Stocks With Upgraded Broker Ratings to Buy Now
Read MoreHide Full Article
Given the current volatile market conditions amid coronavirus-related mayhem and economic slowdown, it is very difficult for retail investors to choose stocks on their own. Therefore, advice from experts becomes extremely crucial.
You can just follow broker rating upgrades. Brokers have deeper insight into stocks, sectors and the overall economy. Moreover, they directly communicate with top management, and thoroughly study publicly available documents as well as attend conference calls. At times, they even interact with customers to better understand product demand.
Further, brokers scrutinize the fundamentals of companies and place them against the current economic backdrop to find out how the stocks will fare as an investment option. So, by following broker rating upgrades, you can easily find attractive stocks.
Nevertheless, depending solely on broker upgrades is not a wise thing to do. You must also take into consideration a few other factors before adding a stock to your investment portfolio. In this way, you can ensure solid returns.
Choosing the Winning Strategy
We have a screening strategy that will help you in your search for potential winners:
Broker Rating Upgrades (four weeks) of 1% or more: The screen selects stocks that have witnessed broker rating upgrades of 1% or more over the last four weeks.
Current Price greater than $5: The stocks must be trading above $5.
Average 20-day Volume greater than 100,000: A large trading volume guarantees that the stock is easily tradable.
Zacks Rank equal to #1 or 2: No matter whether market conditions are good or bad, stocks with a Zacks Rank #1 (Strong Buy) or 2 (Buy) have a proven record of success. You can see the complete list of today’s Zacks #1 Rank stocks here.
VGM Score of A or B: Our research shows that stocks with a VGM Score of A or B when combined with a Zacks Rank #1 or 2 offer the best upside potential.
Here are the three stocks that qualified the screening:
Based in New York, TakeTwo Interactive Software (TTWO - Free Report) is a developer and publisher of video games. The company’s long-term (three to five years) estimated earnings growth rate is 5.7%. The stock, currently carrying a Zacks Rank #2, has witnessed 4.8% upward revision in broker ratings over the past four weeks.
Gilead Sciences (GILD - Free Report) is a pioneer in developing drugs for the treatment of human immunodeficiency virus, liver diseases, hematology/oncology diseases and inflammation/respiratory diseases. This Foster City, CA-based company’s long-term estimated earnings growth rate is 3.7%. The stock, carrying a Zacks Rank #2 at present, has witnessed 4.8% upward revision in broker ratings over the past four weeks.
Based in Tarrytown, NY, Regeneron Pharmaceuticals (REGN - Free Report) is a biopharmaceutical company focused on the discovery, development and commercialization of treatments targeting serious medical conditions. Its long-term estimated earnings growth rate is 19.1%. The stock, currently carrying a Zacks Rank #2, has witnessed 5% upward revision in broker ratings over the past four weeks.
The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.
Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.
Image: Bigstock
3 Top-Ranked Stocks With Upgraded Broker Ratings to Buy Now
Given the current volatile market conditions amid coronavirus-related mayhem and economic slowdown, it is very difficult for retail investors to choose stocks on their own. Therefore, advice from experts becomes extremely crucial.
You can just follow broker rating upgrades. Brokers have deeper insight into stocks, sectors and the overall economy. Moreover, they directly communicate with top management, and thoroughly study publicly available documents as well as attend conference calls. At times, they even interact with customers to better understand product demand.
Further, brokers scrutinize the fundamentals of companies and place them against the current economic backdrop to find out how the stocks will fare as an investment option. So, by following broker rating upgrades, you can easily find attractive stocks.
Nevertheless, depending solely on broker upgrades is not a wise thing to do. You must also take into consideration a few other factors before adding a stock to your investment portfolio. In this way, you can ensure solid returns.
Choosing the Winning Strategy
We have a screening strategy that will help you in your search for potential winners:
Broker Rating Upgrades (four weeks) of 1% or more: The screen selects stocks that have witnessed broker rating upgrades of 1% or more over the last four weeks.
Current Price greater than $5: The stocks must be trading above $5.
Average 20-day Volume greater than 100,000: A large trading volume guarantees that the stock is easily tradable.
Zacks Rank equal to #1 or 2: No matter whether market conditions are good or bad, stocks with a Zacks Rank #1 (Strong Buy) or 2 (Buy) have a proven record of success. You can see the complete list of today’s Zacks #1 Rank stocks here.
VGM Score of A or B: Our research shows that stocks with a VGM Score of A or B when combined with a Zacks Rank #1 or 2 offer the best upside potential.
Here are the three stocks that qualified the screening:
Based in New York, TakeTwo Interactive Software (TTWO - Free Report) is a developer and publisher of video games. The company’s long-term (three to five years) estimated earnings growth rate is 5.7%. The stock, currently carrying a Zacks Rank #2, has witnessed 4.8% upward revision in broker ratings over the past four weeks.
Gilead Sciences (GILD - Free Report) is a pioneer in developing drugs for the treatment of human immunodeficiency virus, liver diseases, hematology/oncology diseases and inflammation/respiratory diseases. This Foster City, CA-based company’s long-term estimated earnings growth rate is 3.7%. The stock, carrying a Zacks Rank #2 at present, has witnessed 4.8% upward revision in broker ratings over the past four weeks.
Based in Tarrytown, NY, Regeneron Pharmaceuticals (REGN - Free Report) is a biopharmaceutical company focused on the discovery, development and commercialization of treatments targeting serious medical conditions. Its long-term estimated earnings growth rate is 19.1%. The stock, currently carrying a Zacks Rank #2, has witnessed 5% upward revision in broker ratings over the past four weeks.
The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.
Click here to sign up for a free trial to the Research Wizard today.
Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.
Disclosure: Performance information for Zacks’ portfolios and strategies are available at: https://www.zacks.com/performance